Studying of two different techniques of radiation therapy in breast cancer patients after tumor excision surgery.

Comparison of sequential and simultaneous integrated boost hypofractionated radiotherapy in patients with breast cancer

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013008

Enrollment

Registered

2018-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- STABLE, FIT FOR TREATMENT

Interventions

Intervention1: Arm A: Simultaneous integrated boost IMRT. Total duration of radiation treatment will be 2 weeks. one treatment fraction per day. Dose will be 34 Gy to whole breast along with 40 Gy t

Eligibility

Inclusion criteria

Inclusion criteria: BREAST CANCER PATIENTS AFTER BREAST CONSERVING SURGERY

Exclusion criteria

Exclusion criteria: patients with poor KPS (performance status ) patients with double malignancy patients with history of prior radiation patients >70 years of age

Design outcomes

Primary

Measure	Time frame
Dosimetry and cosmetic outcomes and acute toxicities Timepoint: Post radiation, 1 month, 3 months, 6 months	—

Secondary

Measure	Time frame
Late toxicities, locoregional control, TOXICITIES, disease free survival, event free survival, overall survival.Timepoint: immediately post radiation, 1 month post radiation, 3 month post radiation, 6 month post radiation	—

Countries

India

Contacts

Public ContactDr Budhi Singh Yadav

PGIMER

drbudhi@gmail.com9815981176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026